21 SEP 2007 General News

Osaka 2007 – no positive tests during the IAAF World Championships

IAAF Logo (c)IAAF Logo (c) © Copyright

MonteCarloThe IAAF is pleased to confirm that the 11th IAAF World Championships in Athletics, Osaka 2007, saw the implementation of the largest ever anti-doping programme at an athletics event.

IAAF President Lamine Diack said: “I am pleased to report that the testing programme in Osaka was the largest ever conducted by the IAAF with even more tests collected than we had initially planned.  I can confirm that we have found only one positive case from the testing in Japan.”

“I am also pleased that once again our efforts to provide an educational forum for athletes via the anti-doping outreach programme proved to be extremely popular.”

“We now have an important year ahead of us as we look forward to Beijing and must continue to work hard to prevent doping in our sport”, said President Diack.

In total, 1132 samples were collected both pre-competition and in-competition on a total of 976 individual athletes. This figure is greater than the 1000 samples originally planned by the IAAF.
In addition to the figures above, 82 athletes were tested during their team training camps in Japan as part of the ongoing IAAF out-of-competition testing programme.

Testing conducted from the opening of the athlete’s village on 20 August (pre-competition) focused on gathering hematological blood profiles and screening blood samples for the indication of possible EPO abuse. The total number of tests conducted pre-competition was 534 which included 429 blood screens for profiling purposes.

During the championships themselves a total of 598 tests were conducted. Of these tests, 179 were urine tests for the detection of EPO, a further 103 were blood samples taken for the detection of blood transfusions, while the remaining 316 were standard urine tests.

There were no positive tests recorded during the championships or in the pre-competition testing at the athlete’s village.
As already noted, one athlete, Mr. Naman Keita (FRA), tested positive for exogenous administration of testosterone or its metabolites following out-of-competition testing during a team training camp in Japan.  This result has been confirmed by the B sample, and the case will now be dealt with in accordance with IAAF rules and results management procedures.

Anti-Doping Education and Injury prevention

The IAAF again presented an Athlete Outreach Programme aimed at informing and educating athletes on a wide range of anti-doping issues.  Hundreds of athletes and support personnel directly participated in this hugely successful programme, while many other athletes viewed the programme and collected information pamphlets during their visit to the warm-up track.  Also assisting with the programme and promoting drug free sport were IAAF Ambassadors Mike Powell, Stéphane Diagana, and Frank Fredericks.

The IAAF Medical and Anti-Doping Department also participated in an injury prevention study. This first stage conducted in Osaka with the collaboration of the IOC and FIFA involved a survey of all injuries incurred during the Osaka Championships. This data will be added to that already collected and the project aims to find ways of preventing and reducing injuries in the future.

An aggressive testing plan for the next 12 months

The significant effort and planning required to complete this anti-doping programme in Osaka will now provide the perfect platform for the IAAF to once again increase its anti-doping work in the future.

The data, profiles, and feedback collected at these championships will be used to make smarter and more informed decisions regarding the continued implementation of the targeted IAAF anti-doping programme and out-of-competition testing in the lead up to the Beijing Olympics.

IAAF